Literature DB >> 20440766

T cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection.

Karolina A Rygiel1, Helen Robertson, Joseph D P Willet, John G Brain, Alastair D Burt, David E J Jones, John A Kirby.   

Abstract

Loss of bile duct epithelium is characteristic of early chronic rejection following liver transplantation. Recent studies have suggested that intrahepatic biliary epithelial cells can transform into myofibroblasts. This study examines the induction and molecular regulation of this transition during allograft rejection. Immortalized human cholangiocytes were stimulated with either transforming growth factor beta1 (TGFbeta1) or a T cell line, and they were examined for morphological, proteomic, and functional features. Posttransplant liver biopsy sections were also examined. Treatment of cholangiocytes with TGFbeta1 or TGFbeta-presenting T cells induced a bipolar morphology, reduced expression of E-cadherin and zona occludens 1 (ZO-1), and increased vimentin, fibronectin, matrix metalloproteinase 2 (MMP-2), MMP-9, and S100 calcium binding protein A4 (S100A4); treated cells invaded a model basement membrane. Chemokines induced T cell penetration of 3-dimensional, cultured bile duct-like structures and bile ducts in liver biopsy sections. A spatial association was observed between duct-infiltrating T cells and cholangiocyte expression of mesenchymal markers, including S100A4. Inhibition of S100A4 expression in vitro blocked TGFbeta1-mediated loss of E-cadherin and ZO-1 but did not reduce induction of fibronectin, MMP-2, or MMP-9. This study demonstrates the potential for T cells to induce an intrahepatic biliary epithelial-to-mesenchymal cell transition during chronic rejection. Furthermore, S100A4 expression by cholangiocytes was identified as a crucial regulator of this transition. 2010 AASLD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440766     DOI: 10.1002/lt.22029

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

Review 1.  Novel therapeutic targets in primary biliary cirrhosis.

Authors:  Jessica K Dyson; Gideon M Hirschfield; David H Adams; Ulrich Beuers; Derek A Mann; Keith D Lindor; David E J Jones
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

2.  The function of activatable cell-penetrating peptides in human intrahepatic bile duct epithelial cells.

Authors:  Kui Tu; Lijin Zhao; Jin Gu; Pengzhan Yan; Fang Wang; Yu Cao
Journal:  J Bioenerg Biomembr       Date:  2016-11-26       Impact factor: 2.945

3.  Vimentin expression is required for the development of EMT-related renal fibrosis following unilateral ureteral obstruction in mice.

Authors:  Zheng Wang; Alex Divanyan; Frances L Jourd'heuil; Robert D Goldman; Karen M Ridge; David Jourd'heuil; Reynold I Lopez-Soler
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-04

4.  Eosinophils promote epithelial to mesenchymal transition of bronchial epithelial cells.

Authors:  Atsushi Yasukawa; Koa Hosoki; Masaaki Toda; Yasushi Miyake; Yuki Matsushima; Takahiro Matsumoto; Daniel Boveda-Ruiz; Paloma Gil-Bernabe; Mizuho Nagao; Mayumi Sugimoto; Yukiko Hiraguchi; Reiko Tokuda; Masahiro Naito; Takehiro Takagi; Corina N D'Alessandro-Gabazza; Shigeru Suga; Tetsu Kobayashi; Takao Fujisawa; Osamu Taguchi; Esteban C Gabazza
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

5.  Biliary epithelial senescence and plasticity in acute cellular rejection.

Authors:  J G Brain; H Robertson; E Thompson; E H Humphreys; A Gardner; T A Booth; D E J Jones; S C Afford; T von Zglinicki; A D Burt; J A Kirby
Journal:  Am J Transplant       Date:  2013-06-10       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.